Revision as of 21:05, 15 March 2024 editJlwoodwa (talk | contribs)Extended confirmed users, Page movers, New page reviewers, Pending changes reviewers, Rollbackers77,475 edits tag as one source← Previous edit | Latest revision as of 15:49, 8 October 2024 edit undoJWBE (talk | contribs)Extended confirmed users10,127 edits removed Category:Anilines; added Category:4-Aminophenyl compounds using HotCat | ||
Line 62: | Line 62: | ||
] | ] | ||
] | ] | ||
] | ] | ||
Latest revision as of 15:49, 8 October 2024
Chemical compoundThis article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Acediasulfone" – news · newspapers · books · scholar · JSTOR (March 2024) |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.131 |
Chemical and physical data | |
Formula | C14H14N2O4S |
Molar mass | 306.34 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Acediasulfone (INN) is an antimicrobial drug, which also has antimalarial activity. It is a long-acting prodrug of dapsone, which is used for treating leprosy.
Synthesis
Dapsone is somewhat inconvenient to administer to patients because of its rather low water solubility.
In the search for more easily administered drugs, dapsone (1) was reacted with bromoacetic acid to give acediasulfone (2) which can be administered as a water-soluble salt.
References
- Jackson EL (February 1948). "Certain N-alkyl, N-carboxyalkyl and N-hydroxyalkyl derivatives of 4,4'-diaminodiphenyl sulfone". Journal of the American Chemical Society. 70 (2): 680–4. doi:10.1021/ja01182a074. PMID 18907772.
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |